The data presented here demonstrate the importance of CHKA inhibition in decreasing AR levels and repressing PCa growth and invasion, highlighting the potential future benefits of inhibitors of this kinase in the clinical management of PCa. This evidence concerns the gene CHKA and posterior cortical atrophy.